Display options
Share it on

Oncotarget. 2018 Aug 10;9(62):32097. doi: 10.18632/oncotarget.25983. eCollection 2018 Aug 10.

Correction: Genetically enhanced T lymphocytes and the intensive care unit.

Oncotarget

Tiberiu Tat, Huming Li, Catalin-Sorin Constantinescu, Anca Onaciu, Sergiu Chira, Ciprian Osan, Sergiu Pasca, Bobe Petrushev, Vlad Moisoiu, Wilhelm-Thomas Micu, Cristian Berce, Sebastian Tranca, Delia Dima, Ioana Berindan-Neagoe, Jianliang Shen, Ciprian Tomuleasa, Liren Qian

Affiliations

  1. Intensive Care Unit, Ion Chiricuta Clinical Cancer Research, Cluj Napoca, Romania.
  2. Department of Anesthesiology-Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  3. Department of Pulmonary and Critical Care Medicine, Navy General Hospital of PLA, Beijing, China.
  4. Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  5. Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  6. Department of Experimental Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  7. Department of Hematology, Ion Chiricuta Clinical Cancer Research, Cluj Napoca, Romania.
  8. Department of Hematology, Navy General Hospital of PLA, Beijing, China.
  9. Research Center for Functional Genomics and Translational Medicine / Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

PMID: 30174800 PMCID: PMC6112836 DOI: 10.18632/oncotarget.25983

Abstract

[This corrects the article DOI: 10.18632/oncotarget.24637.].

Publication Types